Sclerosis News and Research

RSS

High-quality plant-based diets linked to lower dementia risk

Eating a higher quality plant-based diet is associated with a lower risk of Alzheimer's disease and other related dementias compared to eating a lower quality plant-based diet, according to a study published April 8, 2026, in Neurology, the medical journal of the American Academy of Neurology.

8 Apr 2026

Vitamin D levels in midlife tied to lower dementia risk marker

Having higher levels of vitamin D in the blood in middle age is associated with lower levels of tau protein in the brain, which is a sign of dementia, years later, according to a study published April 1, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

1 Apr 2026

Mono infection associated with threefold higher multiple sclerosis risk

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study published on April 1, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

1 Apr 2026

DNA damage in gray matter neurons linked to MS progression

For decades, multiple sclerosis research has focused on myelin, the insulation around the brain's wiring. Scientists paid less attention to another loss that was happening in parallel: neurons in the cortex, the seat of higher thinking and cognition, were quietly dying.

1 Apr 2026

PRISM ALS: A new global collaboration to expand patient-derived stem cell models and accelerate treatments

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for testing treatments do not currently reflect the diverse nature of the disease - that affects both researchers developing therapies and the people urgently waiting for them.

From ALS Therapy Development Institute (ALS TDI) 1 Apr 2026

Gut immune responses found to trigger brain inflammation in MS

Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS).

27 Mar 2026

Hormonal contraception not associated with prevalence of idiopathic intracranial hypertension

Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased prevalence of a brain pressure disorder called idiopathic intracranial hypertension, according to a meta-analysis published on March 25, 2026, in Neurology, the medical journal of the American Academy of Neurology.

25 Mar 2026

Cancer-fighting antibodies may trigger autoimmune brain disorders

Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated.

25 Mar 2026

Multiple sclerosis prevalence in England doubles due to better diagnosis

Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new study by University College London (UCL) and Imperial College London researchers.

23 Mar 2026

Siemens Healthineers launches brain health research portfolio with first biomarker assays now available

Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for 1.

From Siemens Healthineers 19 Mar 2026

People with type 1 diabetes face higher risk of developing dementia

Having type 1 diabetes is associated with a higher risk of developing dementia, according to a study published March 18, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

18 Mar 2026

Anti-aging drug combination causes brain damage in mice

A two-drug combination frequently used in anti-aging research causes brain damage in mice, University of Connecticut researchers report in the March 16 issue of PNAS.

17 Mar 2026

Swedish study reveals COVID-19 may increase glandular fever risk

Even individuals who did not become seriously ill with COVID-19 may have developed a weakened immune system that could lead to serious illnesses in the future.

17 Mar 2026

Investigational oral therapy shows safety and potential benefits in ALS trial

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinical benefits.

16 Mar 2026

New BrainGate iBCI typing neuroprosthesis can restore communication in patients with paralysis

Loss of communication can be among the most devastating symptoms for patients with paralysis. A new study by investigators from Mass General Brigham Neuroscience Institute and Brown University describes an investigational implantable brain computer interface (iBCI) typing neuroprosthesis that can restore communication with speed and accuracy.

16 Mar 2026

Largest review finds no mental health benefits of medicinal cannabis

A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).

16 Mar 2026

Gene mutation that aids high-altitude survival could repair myelin sheath damage

A genetic mutation that helps animals like yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing nerve damage in conditions such as cerebral paralysis and multiple sclerosis (MS).

13 Mar 2026

New study identifies specific brain cells most vulnerable to ALS and dementia

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia, and other serious impairments.

12 Mar 2026

Multiple concussions linked to slightly worse health in former college athletes

In former college athletes, having had three or more concussions was associated with slightly worse physical, mental, behavioral and cognitive health five years after graduation, according to an article published March 11, 2026, in Neurology, the medical journal of the American Academy of Neurology.

11 Mar 2026

Novel embedding-driven AI for adaptable brain control

Motor imagery (MI) is the mental process of imagining a specific limb movement, such as raising a hand or walking, without physically performing it. These imagined movements generate distinct patterns of brain activity that can be recorded using electroencephalography (EEG).

11 Mar 2026